CLINICAL_TRIALS
trial_result
· 2019-08-21
Clinical Trial Update: Trial of pIL-12/MK-3475 in Metastatic Melanoma [Phase 2]
Summary
Phase 2 trial of pIL-12/MK-3475 in metastatic melanoma completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2019-08-21